Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
vadastuximab talirine
×
Other hematologic neoplasm
×
Clear all
Filters
3
NCT02785900
2018-12-12
CASCADE
Seagen Inc.
Phase 3
Terminated
240 enrolled
20 charts